Search Results - Carrasco, Eva

Refine Results
  1. 1
    Normal Levels of Urinary CC16 Protein. Comments on Beamer et al. Association of Children’s Urinary CC16 Levels with Arsenic Concentrations in Multiple Environmental Media. Int. J. Environ. Res. Public Health 2016, 13, 521.

    Normal Levels of Urinary CC16 Protein. Comments on Beamer et al. Association of Children’s Urinary CC16 Levels with Arsenic Concentrations in Multiple Environmental Media. Int. J.... by García-Nieto, Víctor, Mancini, Domenico, Rodríguez-Carrasco, Eva

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Lack of Effects of Pramipexole on REM Sleep Behavior Disorder in Parkinson Disease

    Lack of Effects of Pramipexole on REM Sleep Behavior Disorder in Parkinson Disease by Kumru, Hatice, Iranzo, Alex, Carrasco, Eva, Valldeoriola, Francesc, Martí, Maria José, Santamaria, Joan, Tolosa, Eduard

    Published 2008
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Adenoid cystic carcinoma with a leptomeningeal dissemination in a ‘wash’ pattern

    Adenoid cystic carcinoma with a leptomeningeal dissemination in a ‘wash’ pattern by Prieto Cuadra, Juan Daniel, Dawid de Vera, Maria Teresa, García Carrasco, Eva, Hierro Martín, M Isabel

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Assessment of Prenatal Exposure to Arsenic in Tenerife Island

    Assessment of Prenatal Exposure to Arsenic in Tenerife Island by Vall, Oriol, Gómez-Culebras, Mario, Garcia-Algar, Oscar, Joya, Xavier, Velez, Dinoraz, Rodríguez-Carrasco, Eva, Puig, Carme

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Correction: Prenatal and Postnatal Exposure to DDT by Breast Milk Analysis in Canary Islands

    Correction: Prenatal and Postnatal Exposure to DDT by Breast Milk Analysis in Canary Islands by Vall, Oriol, Gomez-Culebras, Mario, Puig, Carme, Rodriguez-Carrasco, Eva, Baltazar, Arelis Gomez, Canchucaja, Lizzeth, Joya, Xavier, Garcia-Algar, Oscar

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients

    Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients by Negrouk, Anastassia, Lacombe, Denis, Cardoso, Fatima, Morin, Franck, Carrasco, Eva, Maurel, Joan, Maibach, Rudolf, Aranda, Enrique, Marais, Richard, Stahel, Rolf A

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans

    Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans by Ebbert, Mark TW, Bastien, Roy RL, Boucher, Kenneth M, Martín, Miguel, Carrasco, Eva, Caballero, Rosalía, Stijleman, Inge J, Bernard, Philip S, Facelli, Julio C

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

    Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer by Prat, Aleix, Cheang, Maggie Chon U., Martín, Miguel, Parker, Joel S., Carrasco, Eva, Caballero, Rosalía, Tyldesley, Scott, Gelmon, Karen, Bernard, Philip S., Nielsen, Torsten O., Perou, Charles M.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study

    A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/201... by Ocana, Alberto, Gil-Martin, Marta, Martín, Miguel, Rojo, Federico, Antolín, Silvia, Guerrero, Ángel, Trigo, José Manuel, Muñoz, Montse, Pandiella, Atanasio, Diego, Núria Gonzalo, Bezares, Susana, Caballero, Rosalía, Carrasco, Eva, Urruticoechea, Ander

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial

    Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial by Martin, Miguel, Brase, Jan C, Calvo, Lourdes, Krappmann, Kristin, Ruiz-Borrego, Manuel, Fisch, Karin, Ruiz, Amparo, Weber, Karsten E, Munarriz, Blanca, Petry, Christoph, Rodriguez, Cesar A, Kronenwett, Ralf, Crespo, Carmen, Alba, Emilio, Carrasco, Eva, Casas, Maribel, Caballero, Rosalia, Rodriguez-Lescure, Alvaro

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis

    Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis by Pajares, Bella, Pollán, Marina, Martín, Miguel, Mackey, John R, Lluch, Ana, Gavila, Joaquín, Vogel, Charles, Ruiz-Borrego, Manuel, Calvo, Lourdes, Pienkowski, Tadeusz, Rodríguez-Lescure, Álvaro, Seguí, Miguel Angel, Tredan, Olivier, Antón, Antonio, Ramos, Manuel, Cámara, María del Carmen, Rodríguez-Martín, César, Carrasco, Eva, Alba, Emilio

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study

    Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative b... by Martin, Miguel, Brase, Jan C., Ruiz, Amparo, Prat, Aleix, Kronenwett, Ralf, Calvo, Lourdes, Petry, Christoph, Bernard, Philip S., Ruiz-Borrego, Manuel, Weber, Karsten E., Rodriguez, César A., Alvarez, Isabel M., Segui, Miguel A., Perou, Charles M., Casas, Maribel, Carrasco, Eva, Caballero, Rosalía, Rodriguez-Lescure, Alvaro

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Neoadjuvant Therapy with Weekly Nanoparticle Albumin‐Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011‐02), a Multicenter, Non‐Randomized, Phase II Trial, with a Companion Biomarker Analysis

    Neoadjuvant Therapy with Weekly Nanoparticle Albumin‐Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011‐02), a Multicenter, Non‐R... by Martín, Miguel, Chacón, José I., Antón, Antonio, Plazaola, Arrate, García‐Martínez, Elena, Seguí, Miguel A., Sánchez‐Rovira, Pedro, Palacios, José, Calvo, Lourdes, Esteban, Carmen, Espinosa, Enrique, Barnadas, Agusti, Batista, Norberto, Guerrero, Angel, Muñoz, Montserrat, Romio, Estefania, Rodríguez‐Martín, César, Caballero, Rosalía, Casas, María I., Rojo, Federico, Carrasco, Eva, Antolín, Silvia

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer

    High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer by Alba, Emilio, Lluch, Ana, Ribelles, Nuria, Anton-Torres, Antonio, Sanchez-Rovira, Pedro, Albanell, Joan, Calvo, Lourdes, García-Asenjo, Jose Antonio Lopez, Palacios, Jose, Chacon, Jose Ignacio, Ruiz, Amparo, De la Haba-Rodriguez, Juan, Segui-Palmer, Miguel A., Cirauqui, Beatriz, Margeli, Mireia, Plazaola, Arrate, Barnadas, Agusti, Casas, Maribel, Caballero, Rosalia, Carrasco, Eva, Rojo, Federico

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study

    Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study by Castelló, Adela, Martín, Miguel, Ruiz, Amparo, Casas, Ana M., Baena-Cañada, Jose M, Lope, Virginia, Antolín, Silvia, Sánchez, Pedro, Ramos, Manuel, Antón, Antonio, Muñoz, Montserrat, Bermejo, Begoña, De Juan-Ferré, Ana, Jara, Carlos, Chacón, José I, Jimeno, María A., Rosado, Petra, Díaz, Elena, Guillem, Vicente, Lluch, Ana, Carrasco, Eva, Pérez-Gómez, Beatriz, Vioque, Jesús, Pollán, Marina

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study by Márquez-Rodas, Iván, Pollán, Marina, Escudero, María José, Ruiz, Amparo, Martín, Miguel, Santaballa, Ana, Martínez del Prado, Purificación, Batista, Norberto, Andrés, Raquel, Antón, Antonio, Llombart, Antonio, Fernandez Aramburu, Antonio, Adrover, Encarnación, González, Sonia, Seguí, Miguel Angel, Calvo, Lourdes, Lizón, José, Rodríguez Lescure, Álvaro, Ramón y Cajal, Teresa, Llort, Gemma, Jara, Carlos, Carrasco, Eva, López-Tarruella, Sara

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

    Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy by Santonja, Angela, Sánchez-Muñoz, Alfonso, Lluch, Ana, Chica-Parrado, Maria Rosario, Albanell, Joan, Chacón, José Ignacio, Antolín, Silvia, Jerez, José Manuel, de la Haba, Juan, de Luque, Vanessa, Fernández-De Sousa, Cristina Elisabeth, Vicioso, Luis, Plata, Yéssica, Ramírez-Tortosa, César Luis, Álvarez, Martina, Llácer, Casilda, Zarcos-Pedrinaci, Irene, Carrasco, Eva, Caballero, Rosalía, Martín, Miguel, Alba, Emilio

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study

    Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study by Lope, Virginia, Martín, Miguel, Castelló, Adela, Ruiz, Amparo, Casas, Ana Mª, Baena-Cañada, José Manuel, Antolín, Silvia, Ramos-Vázquez, Manuel, García-Sáenz, José Ángel, Muñoz, Montserrat, Lluch, Ana, de Juan-Ferré, Ana, Jara, Carlos, Sánchez-Rovira, Pedro, Antón, Antonio, Chacón, José Ignacio, Arcusa, Angels, Jimeno, Mª Angeles, Bezares, Susana, Vioque, Jesús, Carrasco, Eva, Pérez-Gómez, Beatriz, Pollán, Marina

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis

    Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis by Martín, Miguel, Martínez, Noelia, Ramos, Manuel, Calvo, Lourdes, Lluch, Ana, Zamora, Pilar, Muñoz, Montserrat, Carrasco, Eva, Caballero, Rosalía, García-Sáenz, José Ángel, Guerra, Eva, Caronia, Daniela, Casado, Antonio, Ruíz-Borrego, Manuel, Hernando, Blanca, Chacón, José Ignacio, De la Torre-Montero, Julio César, Jimeno, María Ángeles, Heras, Lucía, Alonso, Rosario, De la Haba, Juan, Pita, Guillermo, Constenla, Manuel, González-Neira, Anna

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

    Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression by Cheang, Maggie C.U., Martin, Miguel, Nielsen, Torsten O., Prat, Aleix, Voduc, David, Rodriguez-Lescure, Alvaro, Ruiz, Amparo, Chia, Stephen, Shepherd, Lois, Ruiz-Borrego, Manuel, Calvo, Lourdes, Alba, Emilio, Carrasco, Eva, Caballero, Rosalia, Tu, Dongsheng, Pritchard, Kathleen I., Levine, Mark N., Bramwell, Vivien H., Parker, Joel, Bernard, Philip S., Ellis, Matthew J., Perou, Charles M., Di Leo, Angelo, Carey, Lisa A.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: